Meet the team behind c4c! We are a diverse group of people from many different backgrounds, but all of us are working towards a common goal: better medicines for children through European clinical trials. Today’s spotlight is on Lionel Tan, one of the industry representatives helping to steer the direction of c4c. Lionel Tan…
DetailsHow Can a Clinical Data Modelling Tool Be Used to Represent Data Items of Relevance to Paediatric Clinical Trials? Learning from the Conect4children (c4c) Consortium The c4c have published a new article on the Direcht clinical data modelling tool in Applied Sciences. “c4c is piloting the Direcht clinical data modelling tool to model their Cross Cutting…
Detailsc4c have published ‘Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project” in British Journal of Clinical Pharmacology. “The medicine development process is complex and requires time and effort to ensure safety, efficacy and quality. In paediatrics, this process is even more challenging, as it involves a subgroup of…
DetailsBack in November 2016, the first meeting for the constitution of RECLIP was held at La Paz Research Institute in Madrid (IdiPAZ). By that time, the network consisted of 12 reference hospitals, the Foundation for the Promotion of Health and Biomedical Research (FISABIO) and 2 research networks RITIP (Translational Research Network in Pediatric Infectious Diseases)…
DetailsDo you know that only about 30% of medicines in Europe and worldwide are authorized for use in paediatrics and that less than 50% of medicines commonly used in children have been properly evaluated in this population? This rate drops to 10% in the vulnerable patient population in neonatal intensive care. The current consensus is…
Details
